Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Jul 03, 2018

SELL
$101.14 - $118.31 $5,461 - $6,388
-54 Closed
0 $0
Q1 2018

Apr 03, 2018

BUY
$107.21 - $151.94 $5,789 - $8,204
54 New
54 $6,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Washington Trust Bank Portfolio

Follow Washington Trust Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Trust Bank, based on Form 13F filings with the SEC.

News

Stay updated on Washington Trust Bank with notifications on news.